# US 2012/0231036 A1 · Cloned biological material medical device and method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0231036 A1
- Document ID: US20120231036A1
- Status: Published application
- Kind: A1
- Application number: 13/044,591
- Filed: 2011-03-10
- Published: 2012-09-13
- Earliest claimed: 2011-03-10
- Assignees: First Principles, Inc.
- Inventors: Keith A. Raniere
- Web page: https://patentgrep.com/patent/US20120231036A1

## CPC

- A61K 35/16: Blood plasma; Blood serum (umbilical cord blood A61K35/51)
- A61F 2/2442: {Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 35/34: Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44)
- A61K 35/35: Fat tissue; Adipocytes; Stromal cells; Connective tissues (adipose-derived stem cells A61K35/28; collagen A61K38/39)
- A61K 35/36: Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells (islets of Langerhans A61K35/39)
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/3804: {characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells}
- A61L 29/005: {Ingredients of undetermined constitution or reaction products thereof}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61M 1/14: Dialysis systems; Artificial kidneys; Blood oxygenators (semi-permeable membranes characterised by the material, manufacturing processes therefor B01D71/00){; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis}
- A61P 7/02: Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/00: Drugs for immunological or allergic disorders
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A medical device, said medical device, comprises: a first component having a non-biological material; a second component having a cloned biological material, said second component being attached to said first component, wherein said first component and said second component are operatively associated in a non-living medical device for at least one of treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism. In another aspect, a method comprises: preparing a cloned biological material from a tissue or an organ; attaching said biological material to a medical device; interfacing said biological material with the non-biological material; providing treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism.

## Claims

### Claim 1

A medical device, said medical device, comprising:
a first component having a non-biological material;
a second component having a cloned biological material, said second component being attached to said first component; and
wherein said first component and said second component are operatively associated in a non-living medical device for at least one of treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein said biological material is selected from the group consisting of:
shaped tissue structure, shaped organ structure, and biological member.

### Claim 3 (depends on 1)

The medical device of claim 1, wherein said non-biological material is selected from the group consisting of: a carbon, a carbon polymer, an inorganic fiber, a nanofiber, an amorphous carbon, a pyrolytic carbon, a vitreous carbon, a glassy carbon, a metal, an alloy, a silicone elastomer, a rubber, a polymer, a polylysine, a polyglycolic acid, a polyamide, a polyolefin, a polyester, a poly-paradioxane, a polycarbonate, a polyether, a polyvinyl chloride, a polyurethane, a polystyrene, a polyacrylate polyethylene, a polypropylene, a polytetrafluoroethylene.

### Claim 4 (depends on 1)

The medical device of claim 1, wherein said biological material is selected from the group consisting of an atom, a molecule, an enzyme, a protein, a cell, a bone, a tendon, a ligament, a vessel, a muscle, a joint, an artery, a vein, a nerve, a tissue and an organ.

### Claim 5 (depends on 2)

The medical device of claim 2, wherein said biological material is comprised of cloned cells.

### Claim 6 (depends on 1)

The medical device of claim 1, wherein said second component is a tube, a gasket, a bolt or a screw.

### Claim 7 (depends on 6)

The medical device of claim 6, wherein said medical device is a dialysis medical machine and wherein said tube is a dialysis tubing.

### Claim 8 (depends on 6)

The medical device of claim 6, wherein said medical device is an annuloplasty band and wherein said tube is an annuloplasty tubing.

### Claim 9 (depends on 1)

The medical device of claim 1, wherein said medical device is a cardiac assist device, comprising:
a housing, said housing having a controller with cloned cellular material therein;
a plurality of leads for sensing and receiving signals;
an electrode for stimulating electrical pacing pulses to a heart;
an outer sheath surrounding said housing; and
a shaped tissue structure surrounding said outer sheath for protecting a human body from immunological reactions to said outer sheath that may occur from contact with said outer sheath of said cardiac assist device.

### Claim 10 (depends on 9)

The cardiac assist device of claim 9, wherein said shaped tissue structure surrounding said outer sheath is formed from cloned cellular material for preventing the compliment activation of blood.

### Claim 11 (depends on 9)

The cardiac assist device of claim 9, wherein the cardiac assist device is compromised of a said biological member and material selected from a group consisting of:
carbon, carbon polymers, inorganic fibers, nanofibers, amorphous carbon, pyrolytic carbon, vitreous carbon and glassy carbon, metal, alloy, silicone elastomer, rubber, polymer, polylysine, polyglycolic acid, polyamide, polyolefin, polyester, poly-paradioxane, polycarbonate, polyether, polyvinyl chloride, polyurethane, polystyrene, polyacrylate polyethylene, polypropylene, and polytetrafluoroethylene or a combination thereof.

### Claim 12 (depends on 9)

The cardiac assist device of claim 9, wherein said outer sheath is comprised of a metal.

### Claim 13 (depends on 9)

The cardiac assist device of claim 9, wherein said outer sheath is comprised of at least one of an alloy selected from a group consisting of:
a titanium alloy, an iridium alloy, a magnesium alloy, a copper alloy, a platinum alloy, a molybdenium alloy, a stainless steel, a nickel alloy, a nickel-titanium alloy, a tantalum alloy, a cobalt-iron alloy, a chromium cobalt alloy, a chromium cobalt-nickel alloy, a chromium cobalt-nickel molybdenium alloy, a platinum-iridium alloy, and a chromium cobalt-nickel molybdenium alloy.

### Claim 14 (depends on 9)

The cardiac assist device of claim 9, wherein said outer sheath is comprised of at least one polymer.

### Claim 15 (depends on 9)

The cardiac assist device of claim 9, wherein said outer sheath is comprised of at least one carbon polymer or carbon composite.

### Claim 16 (depends on 9)

The cardiac assist device of claim 9, wherein said outer sheath further surrounds said plurality of leads.

### Claim 17 (depends on 9)

The cardiac assist device of claim 9, wherein said leads are unipolar.

### Claim 18 (depends on 9)

The cardiac assist device of claim 9, wherein said leads are bipolar.

### Claim 19 (depends on 9)

The cardiac assist device of claim 9, wherein said leads are a combination of unipolar and bipolar leads.

### Claim 20 (depends on 9)

The cardiac assist device of claim 9, wherein said controller is interfaced with a telemetry system for communicating telemetry to a programmer.

### Claim 21 (depends on 9)

The cardiac assist device of claim 9, wherein said electrode is a ring electrode, a tip electrode or coil electrode.

### Claim 22 (depends on 9)

The cardiac assist device of claim 9, further comprising an amplifier for determining whether a signal exceeds a specified threshold.

### Claim 23

A method comprising:
preparing a cloned biological material from a tissue or an organ; attaching said biological material to a non-living medical device; interfacing said biological material with the non-biological material; and
providing treatment, diagnosis, cure, mitigation and prevention of disease, injury, handicap or condition in a living organism.

### Claim 24 (depends on 23)

The method of claim 23, said preparing said a cloned biological material from said tissue or said organ includes removing a portion of said tissue or said organ from an individual;
isolating a cellular material from said portion of said tissue or said organ;
dissociating said cellular material into a cell suspension using cell separation to obtain desired cells; and
growing the desired cells on a shaped matrix to form said cloned biological material.

### Claim 25 (depends on 24)

The method of claim 24, said removing said portion of said tissue or said organ from said individual includes excising said portion of said tissue or said organ.

### Claim 26 (depends on 24)

The method of claim 24, said isolating said cellular material from said portion of said tissue or said organ includes disaggregating said cellular material from said tissue with a digestive enzyme.

### Claim 27 (depends on 26)

The method of claim 26, said disaggregating said cellular material from said tissue with a digestive enzyme selected from a group consisting of: trysin, chymotrysin, collagenase, elastase, hydraluronidase, DNase, pronase, and dispase.

### Claim 28 (depends on 24)

The method of claim 24, said isolating said cellular material from said portion of said tissue or said organ includes treating said tissue or said organ with a chelating agent.

### Claim 29 (depends on 23)

The method of claim 23, wherein said tissue is a connective tissue.

### Claim 30 (depends on 24)

The method of claim 24, wherein said desired cells are selected from a group consisting of:
pericytes, adipoctyes, macrophages, monocytes, plasma cells, mast cells, and endothelial cells.

### Claim 31 (depends on 23)

The method of claim 23, wherein said tissue is selected from a group consisting of:
articular cartilage, auricular cartilage, costal cartilage, elastic cartilage, fibrous cartilage, hyaline cartilage, meniscal cartilage, and yellow cartilage.

### Claim 32 (depends on 24)

The method of claim 24, wherein said desired cells are articular chronodrocytes from articular cartilage.

### Claim 33 (depends on 23)

The method of claim 23, wherein said tissue is fetal neonatal foreskin.

### Claim 34 (depends on 24)

The method of claim 24, said dissociating said cellular material into said cell suspension using said cell separation to obtain said desired cells, wherein said cell separation is selected from the group consisting of negative separation, filtration, centrifugation, electrophoresis, unit gravity separation, cloning and cell selection, or a combination thereof.

### Claim 35 (depends on 24)

The method of claim 24, wherein said shaped matrix is least one of a tubular structure, a thread-like structure, a twisted rope structure, a flat structure, a sheet structure, a spherical structure, a rod structure, a cubical structure or a combination thereof.

### Claim 36 (depends on 23)

The method of claim 23, further comprising genetically modifying said desired cell to express or inactivate the expression of a protein, an enzyme, or a factor for prevention or reduction of one of at least one of thrombosis, hyperplasia, inflammation, occlusion, immunological reactions and a combination thereof.

### Claim 37 (depends on 23)

The method of claim 23, said preparing said cloned biological material includes removing said portion of said tissue or said organ from a donor.

### Claim 38 (depends on 23)

The method of claim 23, further comprising genetically modifying said desired cell to produce an anticoagulation product.

### Claim 39 (depends on 24)

The method of claim 24, wherein said shaped matrix comprises at least one of a group consisting of:
a porous material, non-porous material, biodegradable material, non-biodegradable material biodegradable material, and a combination thereof.

### Claim 40 (depends on 24)

The method of claim 24, wherein said biodegradable material is selected from the group consisting of a polyglycolic acid, a collagen, a polyorthoester, a polycaprolactone, a collagen sponge, a woven collagen, a gelatin, a polylactic acid, a polyglycolic acid, and combination thereof.

### Claim 41 (depends on 24)

The method of claim 24, wherein said non-biodegradable material is selected from a group consisting of:
a polyamide, a polyester, a polyesteramide, a polystrene, a fluorinated ethylene propylene, a polypropylene, a polyacrylate, polyvinyl, a polycarbonate, a polytetrafluoroethylene, a polyethylene, a polyethylene terapthalate, a silicone, a silicone rubber, a polysulfone, a thermanox, a polyurethane, a polyacrylics, a polyhydroxymethyacrylate, a nitrocellulose, and a cotton.

### Claim 42 (depends on 23)

The method of claim 23, said using said cloned biological material on said non-living medical device or as said part of said medical device includes modifying or refining a shape of said cloned biological material.

### Claim 43 (depends on 23)

The method of claim 23, said using said shaped tissue structure or said shaped organ structure on said medical device or as said part of said medical device includes attaching said shaped tissue structure or said organ structure on said medical device or as said part of said medical device.

### Claim 44 (depends on 24)

The method of claim 24, wherein said medical device is selected from a group consisted of:
a pacemaker, a pacemaker electrode, a mechanical heart valve, an endocardial leads, an artificial heart valve, a cardiac assistance device, an implantable cardiac stimulation device, an implantable pacemaker cardioverter defibrillator (ICD), a cardiac rhythm management device, a coronary shunt, a cerebrospinal fluid shunt, a dialysis machine, catheter, a prosthesis, a vascular implant, an aortic implant, a tissue implant, a cardiovascular implant, an annuloplasty device, a drug delivery device, a medical delivery pump, an effector, and a hemostasis valve.

### Claim 45 (depends on 23)

The method of claim 23, wherein said medical device is comprised of at least two materials selected from a group consisting of:
a shaped tissue structure, a shaped organ structure, and a biological member.

### Claim 46 (depends on 23)

The method of claim 23, wherein said medical device is comprised of at least two different materials selected from a group consisting of:
a shaped tissue structure, a shaped organ structure, a biological member, and a carbon, a carbon polymer, an inorganic fiber, a nanofiber, an amorphous carbon, a pyrolytic carbon, a vitreous carbon, a glassy carbon, a metal, an alloy, a silicone elastomer, a rubber, a polymer, a polylysine, a polyglycolic acid, a polyamide, a polyolefin, a polyester, a polyparadioxane, a polycarbonate, a polyether, a polyvinyl chloride, a polyurethane, a polystyrene, a polyacrylate polyethylene, a polypropylene, and a polytetrafluoroethylene.

### Claim 47 (depends on 23)

The method of claim 23, wherein said non-living medical device is a catheter.

### Claim 48 (depends on 24)

The method of claim 24, wherein said using said cloned biological material as an enclosure on a catheter.

### Claim 49 (depends on 23)

The method of claim 23, wherein said cloned biological material is a tube, a gasket, bolt or screw.

### Claim 50 (depends on 23)

The method of claim 23, wherein said medical device is a dialysis medical machine and wherein said tube is a dialysis tube.

### Claim 51 (depends on 50)

The method of claim 50, wherein said medical device is an annuloplasty band and wherein said tube is an annuloplasty tubing.

### Claim 52 (depends on 23)

The method of claim 23, said method, further comprising: creating each and every part of said medical device from at least one of a first group consisting of said shaped tissue structure, said shaped organ structure, and a combination thereof, and at least one of a second group consisting of a biological member and a combination thereof.

### Claim 53 (depends on 52)

The method of claim 52, wherein said biological member is selected from the group consisting of:
an atom, a molecule, an enzyme, a protein, a cell, a bone, a tendon, a ligament, a vessel, a muscle, a joint, an artery, a vein, a nerve, and a tissue and a organ.
